GEORGE V MIGAUSKY Insider Trading
Get free email notifications about insider trading for GEORGE V MIGAUSKY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEORGE V MIGAUSKY. GEORGE V MIGAUSKY is a Chief Financial Officer in IGEN INTERNATIONAL INC /DE ($IGEN) and a EVP & Chief Financial Officer in DYAX CORP ($DYAX) and a Director in Dimension Therapeutics, Inc. ($DMTX) and a Director in Immunovant, Inc. ($HSAC).
Address: 16020 INDUSTRIAL DR GAITHERSBURG 20877 MD
Companies in which GEORGE V MIGAUSKY is an Insider
Dimension Therapeutics, Inc.
Trading Symbol: DMTXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEORGE V MIGAUSKY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 07 2017
$DMTX Market Capitalization: $41.32M
$DMTX Previous Close: $1.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DYAX CORP
Trading Symbol: DYAXIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of GEORGE V MIGAUSKY: EVP & Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Jan 22 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IGEN INTERNATIONAL INC /DE
Trading Symbol: IGENIndustry: PATENT OWNERS & LESSORS [6794]
Position of GEORGE V MIGAUSKY: Chief Financial Officer
Holdings: 114,967 shares
Current Value: $11,497
Latest Transaction: Feb 10 2004
$IGEN Market Capitalization: $2.78M
$IGEN Previous Close: $0.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Immunovant, Inc.
Trading Symbol: IMVTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEORGE V MIGAUSKY: Director
Holdings: 60,200 shares
Latest Transaction: Mar 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GEORGE V MIGAUSKY
Sentiment: All, DMTX, DYAX, IGEN, IMVT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | IMVT | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Option Exercise | A | 17.00 | 23,300 | 396,100 | 23,300 | |
Mar 23 2021 | IMVT | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Grant | A | 0.00 | 15,500 | 0 | 60,200 | 44.7 K to 60.2 K (+34.68 %) |
May 18 2020 | HSAC | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Option Exercise | A | 19.01 | 37,000 | 703,370 | 37,000 | |
May 18 2020 | HSAC | Immunovant, Inc. | MIGAUSKY GEORGE V | Director | Grant | A | 0.00 | 24,700 | 0 | 24,700 | 0 to 24.7 K |
Nov 07 2017 | DMTX | Dimension Therapeu ... | MIGAUSKY GEORGE V | Director | Option Exercise | D | 1.15 | 17,000 | 19,550 | 0 | |
Nov 07 2017 | DMTX | Dimension Therapeu ... | MIGAUSKY GEORGE V | Director | Option Exercise | D | 7.08 | 32,069 | 227,049 | 0 | |
Nov 07 2017 | DMTX | Dimension Therapeu ... | MIGAUSKY GEORGE V | Director | Option Exercise | D | 4.09 | 55,772 | 228,107 | 0 |